Navigation Links
Lasker Foundation Welcomes Elias Zerhouni to Board of Directors

Former Director of National Institutes of Health

NEW YORK, Feb. 3 /PRNewswire/ -- The Albert and Mary Lasker Foundation announced today the election of Dr. Elias A. Zerhouni, the immediate past director of the National Institutes of Health and leader in biomedical research, to its Board of Directors.

"We are delighted that Dr. Zerhouni has agreed to join our Board of Directors," said Dr. Maria C. Freire, President of the Lasker Foundation. "The Lasker Foundation is entering a new era of opportunities for scientific advancement with the bold vision and spirit that drove our founders to transform the landscape of biomedical research. Dr. Zerhouni's vast experience will be a great asset to the Foundation."

"I am honored and I am looking forward to contributing to the noble missions of the Lasker Foundation in these days of rapid and challenging transformations in science and health," said Dr. Zerhouni.

Dr. Alfred Sommer, Chairman of the Lasker Foundation and Dean Emeritus of the Bloomberg School of Public Health of Johns Hopkins University, joined Dr. Freire in expressing his enthusiasm. He said, "Dr. Zerhouni is a highly-respected leader in medicine worldwide, and he will bring much to the Board's deliberations."

Dr. Zerhouni served as director of the US National Institutes of Health (NIH) the world's foremost biomedical research agency from 2002 to 2008. He launched the NIH Roadmap for Medical Research in 2003 to fund compelling initiatives that no single NIH institute could support and established a series of new programs to encourage high-risk innovative research, to enhance interdisciplinary research at the interface of the physical and biological sciences, and to increase support for the independence of early career scientists. During his tenure, NIH tripled its international funding for global health, and it launched comprehensive plans for health disparities, obesity research, and the neurosciences.

About the Lasker Foundation:

The Albert and Mary Lasker Foundation fosters the prevention and treatment of disease and disabilities by honoring excellence in basic and clinical science, by educating the public, and by advocating for support of medical research.

Founded in 1942, the Lasker Foundation presents the prestigious Lasker Awards, which recognize the world's leaders in basic and clinical medical research, and individuals with outstanding public service. For much of the 20th Century, the Lasker Foundation was led by Mary Lasker, who was America's most prominent citizen-activist for public investment in medical research. Mary Lasker is widely credited with prodding the White House and the Congress to greatly expand federal funding for medical research, particularly through the National Institutes of Health.

Further information about the Albert and Mary Lasker Foundation is available at

SOURCE The Albert and Mary Lasker Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Discoverers of Small Regulatory RNAs and Cholesterol-Lowering Drugs to Receive Lasker Awards for Medical Research
2. Foundation Kicks off First-Ever PLS Awareness Month
3. Smithfield Foods Lean Generation(R) Deli Partnership with National Breast Cancer Foundation Celebrates $135,000 Contribution
4. National Patient Advocate Foundation Founder Testifies Before U.S. Senate Health Committee on Methods to Improve Healthcare Quality and Patient Outcomes
5. Today Show and American Legacy Foundation(R) Team Up to Help Smokers Call it Quits
6. The SCAN Foundation Grants $5 Million to the Health Technology Center to Establish National Center for Technology and Aging
7. Defeat Diabetes Foundation Announces R & B Singer Howard Hewett as National Spokesperson
8. Dave Annable Named Christopher & Dana Reeve Foundation Ambassador
9. Glaucoma Research Foundation to Hold Annual Fundraising Benefit
10. The SCAN Foundation Funds New Program for Santa Clarita and South Los Angeles Seniors and Those Who Care for Them
11. Michael J. Fox Foundation Awards $2.5 Million for Parkinsons Drug Development Projects Led By Academic Investigators
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)...  As the latest Obamacare repeal effort moves is ... (R-LA) and Lindsey Graham (R-SC) medical device ... industry is in an odd place.  The industry wants ... tax on medical device sales passed along with the ... increased visits and hospital customers with the funding to ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: